
LPA2 antagonist 2
CAS No. 36840-10-5
LPA2 antagonist 2( —— )
Catalog No. M32997 CAS No. 36840-10-5
LPA2 antagonist 2 is a selective and potent LPA2 antagonist (IC50: 28.3 nM) with potential anticancer activity, inhibits LPA3, and can be used in the study of cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 147 | Get Quote |
![]() ![]() |
5MG | 227 | Get Quote |
![]() ![]() |
10MG | 359 | Get Quote |
![]() ![]() |
25MG | 576 | Get Quote |
![]() ![]() |
50MG | 812 | Get Quote |
![]() ![]() |
100MG | 1071 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLPA2 antagonist 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionLPA2 antagonist 2 is a selective and potent LPA2 antagonist (IC50: 28.3 nM) with potential anticancer activity, inhibits LPA3, and can be used in the study of cancer.
-
DescriptionLPA2 antagonist 2 (H2L 5226501) is a selective LPA2 antagonist with an IC50 of 28.3 nM and a Ki of 21.1 nM. LPA2 antagonist 2 is >480-fold more selective than LPA3 (IC50 of 13.85 μM).
-
In VitroLysophosphatidic acid (LPA) is a phospholipid mediator that elicits a host of biological effects including cell proliferation, survival, motility and differentiation. LPA has been shown to regulate cancer cell invasion, metastasis, and resistance to both chemotherapeutics and radiation. LPA2 antagonist 2 (H2L 5226501) inhibits LPA1 with an Imax of 59.0% at 30 μM.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetLPA Receptor
-
RecptorLPA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36840-10-5
-
Formula Weight380.35
-
Molecular FormulaC20H16N2O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (219.09 mM; Ultrasonic )
-
SMILESO=C(O)C=CC(=O)NC=1C=CC(=CC1)C2=CC=C(C=C2)NC(=O)C=CC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fells JI, et al. Identification of non-lipid LPA3 antagonists by virtual screening. Bioorg Med Chem. 2008 Jun 1;16(11):6207-17.?
molnova catalog



related products
-
DBIBB
DBIBB is a non-lipid agonist of specific lysophosphatidic acid (LPA2) type 2 G-protein-coupled receptor.
-
AM095 free acid
AM095 (free acid) is a potent LPA1 receptor antagonist (IC50s: 0.98 and 0.73 μM for recombinant human or mouse LPA1).In vitro, AM095 was a potent LPA receptor antagonist because it inhibited GTPγS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA with IC values of 0.98 and 0.73 μM, respectively, and exhibited no LPA agonism.
-
Radioprotectin-1
Radioprotectin-1 is a selective agonist of LPA2 with EC50 of 25 nM for murine LPA2 GPCR and exerts radioprotective and radiomitigative action.